Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy
NL Benowitz
and
SG Gourlay
San Francisco General Hospital Medical Center and Department of Medicine, University of California San Francisco, 94143-1220, USA. nbeno@itsa.ucsf.edu
This review discusses the known cardiovascular effects of smoking and the effects of nicotine without tobacco smoke and interprets the available data on cardiovascular risk during nicotine replacement therapy (NRT). Nicotine gum and patches are now approved for over the counter sale in the United States. Smokers with cardiovascular disease are advised to seek physician counseling before using nicotine products, but information regarding the safety of these products in such patients is not readily available to most physicians. Nicotine may contribute to cardiovascular disease, presumably by hemodynamic consequences of sympathetic neural stimulation and systemic catecholamine release. However, there are many potential cardiovascular toxins in cigarette smoke other than nicotine. The doses of nicotine obtained by regular cigarette smoking generally exceed those delivered by NRTs, and the cardiovascular effects of nicotine are, in general, more intense when delivered rapidly by cigarette smoking than the slower delivery by transdermal nicotine or nicotine gum. Because the dose-cardiovascular response relation for nicotine is flat, the effects of cigarette smoking in conjunction with NRT are similar to those of cigarette smoking alone. Cigarette smoking increases blood coagulability, a major risk factor for acute cardiovascular events, whereas transdermal nicotine does not appear to do so. Clinical trials of NRT in patients with underlying, stable coronary disease suggest that nicotine does not increase cardiovascular risk. At worst, the risks of NRT are no more than those of cigarette smoking. The risks of NRT for smokers, even for those with underlying cardiovascular disease, are small and are substantially outweighed by the potential benefits of smoking cessation.
This article has been cited by other articles:

|
 |

|
 |
 
H. Shan, Y. Zhang, Y. Lu, Y. Zhang, Z. Pan, B. Cai, N. Wang, X. Li, T. Feng, Y. Hong, et al.
Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines
Cardiovasc Res,
August 1, 2009;
83(3):
465 - 472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Goette
Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke?
Cardiovasc Res,
August 1, 2009;
83(3):
421 - 422.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A Paciullo, M. R Short, D. T Steinke, and H. R Jennings
Impact of Nicotine Replacement Therapy on Postoperative Mortality Following Coronary Artery Bypass Graft Surgery
Ann. Pharmacother.,
July 1, 2009;
43(7):
1197 - 1202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Ossip, S. M. Abrams, M. C. Mahoney, D. Sall, and K. M. Cummings
Adverse effects with use of nicotine replacement therapy among quitline clients
Nicotine Tob Res,
April 1, 2009;
11(4):
408 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Hudmon and R. L. Corelli
ASHP Therapeutic Position Statement on the Cessation of Tobacco Use
Am. J. Health Syst. Pharm.,
February 1, 2009;
66(3):
291 - 307.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mariscalco and K. G. Engstrom
Are current smokers paradoxically protected against atrial fibrillation after cardiac surgery?
Nicotine Tob Res,
January 27, 2009;
(2009)
ntn011v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Overland, J Hetland, and L E Aaro
Relative harm of snus and cigarettes: what do Norwegian adolescents say?
Tob. Control,
December 1, 2008;
17(6):
422 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gu, V. Pandey, D. L. Geenen, S. A.K. Chowdhury, and M. R. Piano
Cigarette smoke-induced left ventricular remodelling is associated with activation of mitogen-activated protein kinases
Eur J Heart Fail,
November 1, 2008;
10(11):
1057 - 1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Barutcu, A. M. Esen, D. Kaya, E. Onrat, M. Melek, A. Celik, C. Kilit, M. Turkmen, O. Karakaya, O. B. Esen, et al.
Effect of Acute Cigarette Smoking on Left and Right Ventricle Filling Parameters: A Conventional and Tissue Doppler Echocardiographic Study in Healthy Participants
Angiology,
July 1, 2008;
59(3):
312 - 316.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Steinberg, A. C. Schmelzer, D. L. Richardson, and J. Foulds
The Case for Treating Tobacco Dependence as a Chronic Disease
Ann Intern Med,
April 1, 2008;
148(7):
554 - 556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Karakaya, I. Barutcu, D. Kaya, A. M. Esen, M. Saglam, M. Melek, E. Onrat, M. Turkmen, O. B. Esen, and C. Kaymaz
Acute Effect of Cigarette Smoking on Heart Rate Variability
Angiology,
November 1, 2007;
58(5):
620 - 624.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Goette, U. Lendeckel, A. Kuchenbecker, A. Bukowska, B. Peters, H. U Klein, C. Huth, and C. Rocken
Cigarette smoking induces atrial fibrosis in humans via nicotine
Heart,
September 1, 2007;
93(9):
1056 - 1063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Najem, A. Houssiere, A. Pathak, C. Janssen, D. Lemogoum, O. Xhaet, N. Cuylits, and P. van de Borne
Acute Cardiovascular and Sympathetic Effects of Nicotine Replacement Therapy
Hypertension,
June 1, 2006;
47(6):
1162 - 1167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Hubbard, S Lewis, C Smith, C Godfrey, L Smeeth, P Farrington, and J Britton
Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death
Tob. Control,
December 1, 2005;
14(6):
416 - 421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. O. Warner
Helping Surgical Patients Quit Smoking: Why, When, and How
Anesth. Analg.,
August 1, 2005;
101(2):
481 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Ford and J. A. Zlabek
Nicotine Replacement Therapy and Cardiovascular Disease
Mayo Clin. Proc.,
May 1, 2005;
80(5):
652 - 656.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Arredondo, A. I. Chernyavsky, L. M. Marubio, A. L. Beaudet, D. L. Jolkovsky, K. E. Pinkerton, and S. A. Grando
Receptor-Mediated Tobacco Toxicity: Regulation of Gene Expression through {alpha}3{beta}2 Nicotinic Receptor in Oral Epithelial Cells
Am. J. Pathol.,
February 1, 2005;
166(2):
597 - 613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. O. Warner
Preoperative Smoking Cessation: The Role of the Primary Care Provider
Mayo Clin. Proc.,
February 1, 2005;
80(2):
252 - 258.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J Dunsby and L Bero
A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes
Tob. Control,
December 1, 2004;
13(4):
362 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Sivarajan Froelicher, N. H. Miller, D. J. Christopherson, K. Martin, K. M. Parker, M. Amonetti, Z. Lin, M. Sohn, N. Benowitz, C.B. Taylor, et al.
High Rates of Sustained Smoking Cessation in Women Hospitalized With Cardiovascular Disease: The Women's Initiative for Nonsmoking (WINS)
Circulation,
February 10, 2004;
109(5):
587 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hayashi, C. Omichi, Y. Miyauchi, W. J. Mandel, S.-F. Lin, P.-S. Chen, and H. S. Karagueuzian
Age-related sensitivity to nicotine for inducible atrial tachycardia and atrial fibrillation
Am J Physiol Heart Circ Physiol,
November 1, 2003;
285(5):
H2091 - H2098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Shiffman, J R Hughes, J L Pillitteri, and S L Burton
Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample
Tob. Control,
September 1, 2003;
12(3):
310 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Asplund, S. Nasic, U. Janlert, and B. Stegmayr
Smokeless Tobacco as a Possible Risk Factor for Stroke in Men: A Nested Case-Control Study
Stroke,
July 1, 2003;
34(7):
1754 - 1759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W Sumner II
Estimating the health consequences of replacing cigarettes with nicotine inhalers
Tob. Control,
June 1, 2003;
12(2):
124 - 132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Charlson and O. W. Isom
Care after Coronary-Artery Bypass Surgery
N. Engl. J. Med.,
April 10, 2003;
348(15):
1456 - 1463.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Suzuki, E. Bayna, E. Dalle Molle, and W. Y. W. Lew
Nicotine inhibits cardiac apoptosis induced by lipopolysaccharide in rats
J. Am. Coll. Cardiol.,
February 5, 2003;
41(3):
482 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ji, T. Tosaka, B. H. Whitfield, A. N. Katchman, A. Kandil, B. C. Knollmann, and S. N. Ebert
Differential Rate Responses to Nicotine in Rat Heart: Evidence for Two Classes of Nicotinic Receptors
J. Pharmacol. Exp. Ther.,
June 1, 2002;
301(3):
893 - 899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Benowitz, A. Hansson, and P. Jacob III
Cardiovascular Effects of Nasal and Transdermal Nicotine and Cigarette Smoking
Hypertension,
June 1, 2002;
39(6):
1107 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Anderson, D. E. Jorenby, W. J. Scott, and M. C. Fiore
Treating Tobacco Use and Dependence : An Evidence-Based Clinical Practice Guideline for Tobacco Cessation
Chest,
March 1, 2002;
121(3):
932 - 941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Rigotti
Treatment of Tobacco Use and Dependence
N. Engl. J. Med.,
February 14, 2002;
346(7):
506 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Sekhon, J. A. Keller, B. J. Proskocil, E. L. Martin, and E. R. Spindel
Maternal Nicotine Exposure Upregulates Collagen Gene Expression in Fetal Monkey Lung . Association with alpha 7 Nicotinic Acetylcholine Receptors
Am. J. Respir. Cell Mol. Biol.,
January 1, 2002;
26(1):
31 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Luty
Nicotine addiction and smoking cessation treatments
Adv. Psychiatr. Treat.,
January 1, 2002;
8(1):
42 - 48.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zevin, S. Saunders, S. G. Gourlay, P. Jacob III, and N. L. Benowitz
Cardiovascular effects of carbon monoxide and cigarette smoking
J. Am. Coll. Cardiol.,
November 15, 2001;
38(6):
1633 - 1638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.P. Pellegrini, D. E Newby, S. Maxwell, and D. J Webb
Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man
Cardiovasc Res,
November 1, 2001;
52(2):
321 - 327.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Black, N. Huang, P. C. Neligan, R. H. Levine, J. E. Lipa, S. Lintlop, C. R. Forrest, and C. Y. Pang
Effect of nicotine on vasoconstrictor and vasodilator responses in human skin vasculature
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2001;
281(4):
R1097 - R1104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.P. Mathew and N.A. Herity
Acute myocardial infarction soon after nicotine replacement therapy
QJM,
September 1, 2001;
94(9):
503 - 504.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. T KOZLOWSKI, A. A STRASSER, G. A GIOVINO, P. A ERICKSON, and J. V TERZA
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
Tob. Control,
September 1, 2001;
10(3):
201 - 203.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Kimmel, J. A. Berlin, C. Miles, J. Jaskowiak, J. L. Carson, and B. L. Strom
Risk of acute first myocardial infarction and use of nicotine patches in a general population
J. Am. Coll. Cardiol.,
April 1, 2001;
37(5):
1297 - 1302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vayssier-Taussat, T. Camilli, Y. Aron, C. Meplan, P. Hainaut, B. S. Polla, and B. Weksler
Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses
Am J Physiol Heart Circ Physiol,
March 1, 2001;
280(3):
H1293 - H1300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hjemdahl
Smoking, nicotine and thrombotic risk -- a role for platelet dependent thrombin generation?
Eur. Heart J.,
January 1, 2001;
22(1):
16 - 18.
[PDF]
|
 |
|

|
 |

|
 |
 
R. West, A. McNeill, and M. Raw
Smoking cessation guidelines for health professionals: an update
Thorax,
December 1, 2000;
55(12):
987 - 999.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Wang, H. Shi, L. Zhang, M. Pourrier, B. Yang, S. Nattel, and Z. Wang
Nicotine Is a Potent Blocker of the Cardiac A-Type K+ Channels : Effects on Cloned Kv4.3 Channels and Native Transient Outward Current
Circulation,
September 5, 2000;
102(10):
1165 - 1171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. O Fagerström, J. R Hughes, T. Rasmussen, and P. W Callas
Randomised trial investigating effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit
Tob. Control,
September 1, 2000;
9(3):
327 - 333.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. L Benowitz, D. A Dempsey, R. L Goldenberg, J. R Hughes, P. Dolan-Mullen, P. L Ogburn, C. Oncken, C T. Orleans, T. A Slotkin, H P. Whiteside Jr, et al.
The use of pharmacotherapies for smoking cessation during pregnancy
Tob. Control,
September 1, 2000;
9(90003):
91i - 94.
[Full Text]
|
 |
|

|
 |

|
 |
 
N. A. Rigotti
A 36-Year-Old Woman Who Smokes Cigarettes
JAMA,
August 9, 2000;
284(6):
741 - 749.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D Balfour, N Benowitz, K Fagerstrom, M Kunze, and U Keil
Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report
Eur. Heart J.,
March 2, 2000;
21(6):
438 - 445.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T.F.M. Van Berkel, H. Boersma, J.W. Roos-Hesselink, R.A.M. Erdman, and M.L. Simoons
Impact of smoking cessation and smoking interventions in patients with coronary heart disease
Eur. Heart J.,
December 2, 1999;
20(24):
1773 - 1782.
[PDF]
|
 |
|

|
 |

|
 |
 
F. Huhtasaari, V. Lundberg, M. Eliasson, U. Janlert, and K. Asplund
Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men
J. Am. Coll. Cardiol.,
November 15, 1999;
34(6):
1784 - 1790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Z. Wang, H. Shi, S.-J. Liao, and Z. Wang
Inactivation gating determines nicotine blockade of human HERG channels
Am J Physiol Heart Circ Physiol,
September 1, 1999;
277(3):
H1081 - H1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Hughes, M. G. Goldstein, R. D. Hurt, and S. Shiffman
Recent Advances in the Pharmacotherapy of Smoking
JAMA,
January 6, 1999;
281(1):
72 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Narkiewicz, P. J.H. van de Borne, M. Hausberg, R. L. Cooley, M. D. Winniford, D. E. Davison, and V. K. Somers
Cigarette Smoking Increases Sympathetic Outflow in Humans
Circulation,
August 11, 1998;
98(6):
528 - 534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Benowitz
Treating Tobacco Addiction -- Nicotine or No Nicotine?
N. Engl. J. Med.,
October 23, 1997;
337(17):
1229 - 1231.
[Full Text]
|
 |
|

|
 |

|
 |
 
K. E. Warner, J. Slade, and D. T. Sweanor
The Emerging Market for Long-term Nicotine Maintenance
JAMA,
October 1, 1997;
278(13):
1087 - 1092.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Lightwood and S. A. Glantz
Short-term Economic and Health Benefits of Smoking Cessation : Myocardial Infarction and Stroke
Circulation,
August 19, 1997;
96(4):
1089 - 1096.
[Abstract]
[Full Text]
|
 |
|
|